INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insperity, Inc. - NSP

03.09.25 16:00 Uhr

Werte in diesem Artikel
Aktien

42,20 EUR -0,40 EUR -0,94%

NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Insperity, Inc. ("Insperity" or the "Company") (NYSE: NSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Insperity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On August 1, 2025, Insperity issued a press release announcing its financial results for the second quarter of 2025.  Among other items, Insperity reported adjusted earnings per share of only $0.26, missing analyst estimates and representing a 70% year-over-year decline.  Insperity attributed its results to higher-than-expected benefits costs, specifically pointing to rising pharmacy expenses and an increased frequency of large insurance claims. Insperity also lowered its full-year earnings forecast. 

On this news, Insperity's stock price fell $14.51 per share, or 24.35%, to close at $45.07 per share on August 1, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-insperity-inc---nsp-302544818.html

SOURCE Pomerantz LLP

In eigener Sache

Übrigens: Insperity und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Insperity

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Insperity

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Insperity Inc.

Wer­bung

Analysen zu Insperity Inc.

DatumRatingAnalyst
02.08.2018Insperity Equal-WeightFirst Analysis Securities
14.02.2017Insperity OverweightFirst Analysis Securities
07.07.2016Insperity Equal-WeightFirst Analysis Securities
29.04.2016Insperity OutperformRobert W. Baird & Co. Incorporated
11.02.2015Insperity BuyROTH Capital Partners, LLC
DatumRatingAnalyst
14.02.2017Insperity OverweightFirst Analysis Securities
29.04.2016Insperity OutperformRobert W. Baird & Co. Incorporated
11.02.2015Insperity BuyROTH Capital Partners, LLC
25.10.2006Update Administaff Inc.: BuyMatrix Research
06.06.2006Update Administaff Inc.: OutperformCredit Suisse
DatumRatingAnalyst
02.08.2018Insperity Equal-WeightFirst Analysis Securities
07.07.2016Insperity Equal-WeightFirst Analysis Securities
04.11.2014Insperity NeutralROTH Capital Partners, LLC
05.10.2005Update Administaff Inc.: Sector PerformRBC Capital Markets
13.07.2005Update Administaff Inc.: NeutralCredit Suisse First Boston
DatumRatingAnalyst
17.02.2005Update Administaff Inc.: Market UnderperformJMP Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Insperity Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen